# A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy

> **NCT00573261** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00573261
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573261, "A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00573261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*